Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 3/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | HBB | P68871 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | DHFR | P00374 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2559494 | 0.70 | CREBBP (0.44) | SMN1; SMN2ALDH1A1NPSR1LMNATSHR | |
| SCHEMBL11074162 | 0.70 | TP53 (0.47) | KMT2AHTTSMN1; SMN2TP53HBB | |
| SCHEMBL9957165 | 0.69 | NOTUM (0.46) | KMT2ALMNA | |
| SCHEMBL9956084 | 0.68 | NOTUM (0.39) | KMT2AALDH1A1LMNA | |
| SCHEMBL7690976 | 0.67 | DGAT1 (0.36) | — | |
| SCHEMBL10921503 | 0.67 | TP53 (0.52) | SMN1; SMN2TP53HBBALDH1A1NPSR1 | |
| SCHEMBL14352972 | 0.66 | CREBBP (0.57) | KMT2AHTTSMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL5201884 | 0.65 | KDM4E (0.39) | KMT2AHTTGAASMN1; SMN2ALDH1A1 | |
| SCHEMBL22640070 | 0.65 | CARM1 (0.37) | KMT2ASMN1; SMN2TP53ALDH1A1LMNA | |
| SCHEMBL22640006 | 0.65 | CARM1 (0.37) | KMT2ASMN1; SMN2TP53ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7364825-B2 | Charge transport materials having a nitrogen-containing-heterocycle hydrazone group | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-04-29 | — | — | US | disclosed |
| US-20060177750-A1 | Charge transport materials having a nitrogen-containing-heterocycle hydrazone group | S-PRINTING SOLUTION CO., LTD. (KR) | 2006-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060177750-A1 | Charge transport materials having a nitrogen-containing-heterocycle hydrazone group | SLC1A2, SLC9B2, SLC6A19 | KMT2A 3624/4885HTT 906/4885GAA 3934/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.